交易中 12-24 10:10:58 美东时间
+0.060
+0.34%
今日重点评级关注:Guggenheim:维持Cybin Inc. Common Shares"买入"评级,目标价从39美元升至48美元;HC Wainwright & Co.:维持Capricor Therapeutics"买入"评级,目标价从24美元升至60美元
12-04 09:38
Piper Sandler analyst Manuel Navas assumes Meridian (NASDAQ:MRBK) with a Overweight rating and announces Price Target of $19.
12-04 01:29
Meridian Bank (NASDAQ:MRBK) declares $0.125/share quarterly dividend, in line with previous. Forward yield 3.33% Payable Nov. 17; for shareholders of record Nov. 10; ex-div Nov. 10. See MRBK Dividend ...
10-24 12:32
今日重点评级关注:花旗:维持Apellis Pharmaceuticals"买入"评级,目标价从41美元升至46美元;杰富瑞:维持Kiniksa Pharmaceuticals"买入"评级,目标价从45美元升至54美元
07-30 09:36
DA Davidson analyst Russell Gunther maintains Meridian (NASDAQ:MRBK) with a Buy and raises the price target from $17 to $19.
07-30 01:39
Meridian Bank (NASDAQ:MRBK) declares $0.125/share quarterly dividend, in line with previous. Forward yield 3.41% Payable Aug. 18; for shareholders of record Aug. 11; ex-div Aug. 11. See MRBK Dividend ...
07-25 12:12
The latest announcement is out from Meridian Bank ( ($MRBK) ). On July 24, 2025...
07-25 04:17
Meridian Bank ( ($MRBK) ) has provided an announcement. Meridian Bank held its ...
05-23 01:57
Meridian Bank (NASDAQ:MRBK) declares $0.125/share quarterly dividend, in line with previous. Forward yield 3.62% Payable May 19; for shareholders of record May 12; ex-div May 12. See MRBK Dividend Sco...
04-26 02:44
Meridian Bank (MRBK) has disclosed a new risk, in the Regulation category. Meri...
03-18 14:01